Palm Vascular Centers
Palm Vascular Centers is a private outpatient vascular surgery practice operating six centers across South Florida and New York, delivering minimally invasive treatments for PAD, dialysis access, uterine fibroids, and venous insufficiency to patients referred by physicians or self-referred.
- Company typePrivate
- Founded2010
- HeadquartersFort Lauderdale, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Palm Vascular Centers does
Palm Vascular Centers is a privately held outpatient vascular surgery practice founded in 2010 in Miami Beach, now operating six centers across South Florida (Miami-Dade, Broward, and Martin counties) and New York, supported by more than 100 staff and six or more board-certified vascular and interventional radiologists. Its core offering is minimally invasive outpatient treatment of vascular disease, including peripheral arterial disease (PAD) and critical limb ischemia (CLI), dialysis access management, uterine fibroid embolization (UFE), and spider/varicose vein and venous insufficiency therapy, delivered via catheter-based and ultrasound-guided endovascular techniques in state-of-the-art outpatient facilities with same-day discharge. Supporting services include comprehensive vascular ultrasound evaluations, ankle-brachial index testing, and CT and conventional angiography.
The business model is professional services delivered directly to patients and accessed through physician referrals, self-referral via an online appointment system, or insurance billing. Procedures are reimbursed through insurance and self-pay based on procedure complexity; no pricing is publicly disclosed. The practice markets itself as the first outpatient vascular lab in South Florida to operate across multiple counties and emphasizes limb-salvage capability for advanced PAD cases, reporting UFE outcomes such as 85% symptom improvement and 40-70% fibroid shrinkage within six months.
Palm Vascular is owned and operated by its physician group with no disclosed parent company, institutional investor, or funding rounds; it is actively recruiting partner physicians and capital partners via its website. There are no patents, no regulatory actions, no public awards, and no disclosed AI/ML or technology-platform capabilities — the differentiators are clinical specialization, multi-site outpatient scale, and a referral-driven go-to-market motion.
Palm Vascular Centers firmographics
Firmographics- Name
- Palm Vascular Centers
- Legal name
- Palm Vascular Centers
- Website
- https://palmvascular.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Palm Vascular Centers is a private outpatient vascular surgery practice operating six centers across South Florida and New York, delivering minimally invasive treatments for PAD, dialysis access, uterine fibroids, and venous insufficiency to patients referred by physicians or self-referred.
- Ownership category
- akta.pro rank
Palm Vascular Centers industry classification
Industry- Product category
- Outpatient Vascular Surgery Services
- NAICS
- Offices of Physicians (62111), Ambulatory Health Care Services (621)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Vascular Medicine (Peripheral Arterial/Venous Disease) (HLAKABAG)
- akta.pro secondary industries
- Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy) (HLAHAFAE), Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK)
Keywords
Where Palm Vascular Centers is headquartered
LocationHeadquarters
- HQ city
- Fort Lauderdale
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Palm Vascular Centers business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Supply Chain
Revenue model
- Outpatient Vascular Procedures: Revenue generated from minimally invasive vascular procedures performed in outpatient settings including PAD treatments, uterine fibroid embolization, dialysis access management, and spider/varicose vein treatments. Billed through insurance and self-pay based on procedure complexity.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Palm Vascular Centers product offering
Product offeringCore offering
Palm Vascular Centers operates a network of six outpatient vascular surgery centers across South Florida and New York that diagnose and treat vascular disease using minimally invasive, catheter-based and endovascular techniques. Core services include peripheral arterial disease (PAD) treatment at all stages, uterine fibroid embolization (UFE), dialysis access management, venous insufficiency and spider/varicose vein treatments, supported by comprehensive vascular ultrasound diagnostics and angiography. Patients are typically discharged the same day, with the practice positioned as a lower-cost, hospital-free alternative to inpatient vascular care.
Product overview
Palm Vascular Centers operates as a collection of outpatient vascular treatment facilities offering a unified platform of vascular care services. The core offerings include Peripheral Arterial Disease (PAD) treatment, Dialysis Access Management, Uterine Fibroid Embolization (UFE), Spider & Varicose Vein Treatments, and Venous Insufficiency Treatment. Supporting these treatment services are diagnostic capabilities including Comprehensive Vascular Evaluations & Ultrasounds and Angiogram Services. All procedures are performed using minimally invasive techniques in state-of-the-art outpatient facilities.
Differentiator
Problem solved
Functional benefit
Products and services
- Peripheral Arterial Disease (PAD) Treatment Minimally invasive outpatient treatment options for all stages of peripheral arterial disease, including angioplasty and atherectomy, delivered to patients seeking limb-salvage and improved circulation.
- Dialysis Access Management Management and monitoring of dialysis fistulas and grafts, including fistulograms to assess function and maintenance procedures such as angioplasty, thromboembolectomy, vessel mapping, central venous access placement, and arterial stenting for dialysis patients.
- Uterine Fibroid Embolization (UFE) Minimally invasive outpatient procedure using catheter-based embolization to block blood flow to uterine fibroids, preserving the uterus while reducing fibroid symptoms; positioned as an alternative to hysterectomy for women with symptomatic fibroids.
- Spider & Varicose Vein Treatments / Venous Insufficiency Treatment Comprehensive treatment for chronic venous insufficiency and spider/varicose veins, including radiofrequency ablation, phlebectomy, sclerotherapy, and venous stenting, delivered to adult patients with venous disease.
- Comprehensive Vascular Evaluations & Ultrasounds Full diagnostic imaging services including echocardiography, vascular ultrasounds (arterial and venous duplex scans), renal artery Doppler, aorta and IVC duplex scan, carotid artery duplex scan, ankle-brachial index (ABI), pulse-volume recordings (PVR), and AAA screening.
- Angiogram Services Both CT angiography (non-invasive) and conventional coronary angiogram procedures for evaluating artery damage and blockages, used to support vascular diagnosis and treatment planning.
Quantifiable outcome
- Minimally invasive procedures allow same-day discharge and return to normal activities within hours to 1-2 weeks
- +1 more outcomes
Companies that use Palm Vascular Centers
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles3 records
Palm Vascular Centers technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Palm Vascular Centers partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Palm Vascular Centers competitors and assessment
Company assessmentDirect peers
- Azura Vascular Care: National outpatient vascular center network (formerly American Access Care / Fresenius Vascular Care) operating office-based labs for vascular access, PAD, and endovascular interventions — directly comparable service lines.
- USA Vascular Centers: Multi-site office-based lab chain specializing in PAD treatment, uterine fibroid embolization, and outpatient vascular interventions — directly comparable business model, service mix, and patient referral approach to Palm Vascular Centers.
- American Endovascular & Amputation Prevention: Multi-site outpatient endovascular practice specializing in limb salvage and PAD treatment including CLI — directly comparable in clinical focus on critical limb ischemia and outpatient vascular intervention.
- Center for Vascular Medicine: Multi-location outpatient vascular group offering PAD, venous, and dialysis access services across the Mid-Atlantic; comparable in physician-led, outpatient-delivered model for non-cardiac vascular disease.
- Vein Clinics of America: Largest U.S. network of physician-led vein treatment clinics offering radiofrequency ablation, sclerotherapy, and venous insufficiency services — overlapping service mix with Palm Vascular's venous insufficiency and spider/varicose vein offerings.
- Inovia Vein Specialty Centers: Physician-owned multi-location vein center group performing outpatient endovenous thermal ablation, sclerotherapy, and phlebectomy — comparable outpatient, physician-led model with overlapping venous focus.
Emerging players
- MINT Medspa / Minimally Invasive Specialists: Multi-site outpatient interventional radiology practices offering vein treatments and select vascular procedures — partially overlapping with Palm Vascular's venous and interventional radiology service lines.
Broad incumbents
- Fresenius Vascular Care: Subsidiary of Fresenius Medical Care operating outpatient vascular access centers; comparable to Palm Vascular's dialysis access management service line as part of a much larger renal-care platform.
- HCA Florida Healthcare: Large hospital system operating across Florida with vascular surgery programs and increasingly outpatient vascular capabilities — represents hospital-based competitive pressure on Palm Vascular's South Florida footprint.
- CardioVascular Associates: Multi-specialty cardiovascular physician group practice offering vascular services among a broader cardiology portfolio — comparable in physician-led outpatient delivery but broader in scope than Palm Vascular's vascular-only focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Palm Vascular Centers social profiles
Digital presencePalm Vascular Centers financial estimates
Financial estimateRevenue estimate
Valuation estimate
Palm Vascular Centers leadership team
Management profileNumber of profiles
Profiles12 records
Palm Vascular Centers funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Palm Vascular Centers M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Palm Vascular Centers
What does Palm Vascular Centers do?
Palm Vascular Centers operates a network of six outpatient vascular surgery centers across South Florida and New York that diagnose and treat vascular disease using minimally invasive, catheter-based and endovascular techniques. Core services include peripheral arterial disease (PAD) treatment at all stages, uterine fibroid embolization (UFE), dialysis access management, venous insufficiency and spider/varicose vein treatments, supported by comprehensive vascular ultrasound diagnostics and angiography. Patients are typically discharged the same day, with the practice positioned as a lower-cost, hospital-free alternative to inpatient vascular care.
Is Palm Vascular Centers a public or private company?
Palm Vascular Centers is a private company. It is classified as management employee owned and is currently operating.
When was Palm Vascular Centers founded?
Palm Vascular Centers was founded in 2010. It employs 51 to 100 people.
Where is Palm Vascular Centers based?
Palm Vascular Centers is headquartered in Fort Lauderdale, United States, in the North America region.
How does Palm Vascular Centers make money?
One revenue line is on record: outpatient Vascular Procedures.
Who are Palm Vascular Centers's main competitors?
Direct peers on record are Azura Vascular Care, USA Vascular Centers, American Endovascular & Amputation Prevention, Center for Vascular Medicine, Vein Clinics of America and Inovia Vein Specialty Centers. MINT Medspa / Minimally Invasive Specialists is listed as an emerging player. Broad incumbents are Fresenius Vascular Care, HCA Florida Healthcare and CardioVascular Associates.
Does Palm Vascular Centers have an API?
No public API is recorded for Palm Vascular Centers.
What industry is Palm Vascular Centers in?
Palm Vascular Centers's product category is Outpatient Vascular Surgery Services. Its primary akta.pro industry code is HLAKABAG, Vascular Medicine (Peripheral Arterial/Venous Disease), with a secondary code of HLAHAFAE, Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy). Its NAICS code is 62111 and its SIC code is 8011.